SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001415889-15-002843
Filing Date
2015-08-21
Accepted
2015-08-21 16:05:36
Documents
6
Period of Report
2015-08-21
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ecte8k_aug202015.htm 8-K 27608
2 LETTER FROM NASDAQ TO THE COMPANY DATED AUGUST 20, 2015. ex99-1.htm EX-99.1 33699
3 nasdaq.jpg GRAPHIC 4744
4 ex99-118.jpg GRAPHIC 2056
5 ex991p5e.jpg GRAPHIC 191097
6 ex991p6.jpg GRAPHIC 261819
  Complete submission text file 0001415889-15-002843.txt   696159
Mailing Address 99 WOOD AVENUE SOUTH SUITE 302 ISELIN NJ 08830
Business Address 99 WOOD AVENUE SOUTH SUITE 302 ISELIN NJ 08830 732-549-0919
Echo Therapeutics, Inc. (Filer) CIK: 0001031927 (see all company filings)

IRS No.: 411649949 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35218 | Film No.: 151068942
SIC: 3845 Electromedical & Electrotherapeutic Apparatus